- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Homologous recombination deficiency in breast cancer ; day:9 ; month:6 ; year:2020 ; pages:1-5
Magazine of European Medical Oncology ; (9.6.2020), 1-5
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-020-00624-x
- URN
-
urn:nbn:de:101:1-2020080901244879010274
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bartl, Thomas
- Farr, Alex
- SpringerLink (Online service)
Ähnliche Objekte (12)
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination proficiency in ovarian and breast cancer patients
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination proficiency in ovarian and breast cancer patients
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Homologous recombination deficiency in epithelial ovarian cancer
Pan-cancer landscape of homologous recombination deficiency
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
Leveraging homologous recombination repair deficiency in sarcoma
Targeting homologous recombination deficiency in uterine leiomyosarcoma
Homologous recombination proficiency in ovarian and breast cancer patients
Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells